SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 246 filers reported holding SALIX PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $2,298,000 | -80.7% | 13,300 | -87.2% | 0.03% | -80.0% |
| Q4 2014 | $11,929,000 | -16.7% | 103,780 | +13.3% | 0.14% | -20.1% |
| Q3 2014 | $14,314,000 | +13.1% | 91,610 | -10.7% | 0.17% | +15.0% |
| Q2 2014 | $12,652,000 | +9.8% | 102,575 | -7.8% | 0.15% | +8.1% |
| Q1 2014 | $11,525,000 | -36.8% | 111,225 | -45.2% | 0.14% | -35.8% |
| Q4 2013 | $18,242,000 | +29.4% | 202,830 | -3.8% | 0.21% | +64.3% |
| Q3 2013 | $14,101,000 | -20.3% | 210,850 | -21.2% | 0.13% | -22.8% |
| Q2 2013 | $17,692,000 | – | 267,450 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $34,482,000 | 18.91% |
| NORTH RUN CAPITAL, LP | 490,000 | $56,321,000 | 5.02% |
| Visium Asset Management, LP | 3,076,092 | $353,568,000 | 4.99% |
| BOW STREET LLC | 112,979 | $12,986,000 | 4.60% |
| 1492 Capital Management LLC | 62,397 | $7,172,000 | 4.49% |
| CLOVIS CAPITAL MANAGEMENT LP | 115,000 | $13,218,000 | 3.70% |
| Paulson & Co. | 5,806,000 | $667,342,000 | 3.45% |
| HealthCor Management, L.P. | 525,000 | $60,344,000 | 3.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 158,500 | $18,218,000 | 3.10% |
| AMI ASSET MANAGEMENT CORP | 299,276 | $34,399,000 | 3.01% |